Poor response to simvastatin in familial defective apo-B-100
- 1 February 1991
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 337 (8736) , 305
- https://doi.org/10.1016/0140-6736(91)90920-k
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia.Journal of Lipid Research, 1990
- BINDING-DEFECTIVE LOW-DENSITY LIPOPROTEIN IN FAMILY WITH HYPERCHOLESTEROLAEMIAThe Lancet, 1989
- Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100.Proceedings of the National Academy of Sciences, 1989
- A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group IIIPublished by American Medical Association (AMA) ,1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.Proceedings of the National Academy of Sciences, 1987
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986